That's correct.
The concerns would actually more likely be in the opposite direction. In other words, we have their data. They're the sponsor of the clinical trial and they're paying for the clinical trial, but the data is held in Canada. There's no security concern that they may steal those data because they own that data.
I think there was more concern, not from the company's standpoint, but from the Chinese government's standpoint, that the data would be here in Canada and not in China.